natgillin/translations-raw huggingface dataset:
DM-6705 (delamanid active
DM-6705 (aktivni presnovek
DM-6705 exposure may be
izpostavljenost DM-6705 se
DM-6705 exposure may be
potrebno prilagajati odmerka na
DM-6705, if co-administration of
lopinavirjem/ritonavirjem, je
DM-6705, if co-administration of
Pri sočasni uporabi lopinavirje/ritonavirja in valprojske kisline ali valproata je
DM040010 (n=1087)
DM040010 (n = 1.087)
DM040011 (n=1524)
DM040011 (n = 1.524)
DM04010 (n=1087)
DM040010 (n = 1.087)
DM04011 (n=1524)
DM040011 (n = 1.524)
DM1 was aneugenic or clastogenic in an in vivo single-dose rat bone marrow micronucleus assay at exposures that were comparable to mean maximum concentrations of DM1 measured in humans administered trastuzumab emtansine.
V mikrojedrnem preizkusu in vivo na kostnem mozgu podgan z enkratnim odmerkom je bil DM1 anevgeničen ali klastogen ob izpostavljenostih, primerljivih povprečni največji koncentraciji DM1, izmerjeni pri ljudeh, ki so dobili trastuzumab emtanzin.
DM1 – an anti-cancer substance that becomes active once Kadcyla enters the cancer cell.
DM1 – to je učinkovina proti raku, ki postane aktivna, ko zdravilo Kadcyla vstopi v rakavo celico.
DM1, the cytotoxic component of trastuzumab emtansine, binds to tubulin.
DM1, citotoksična komponenta trastuzumaba emtanzina, se veže na tubulin.
DMPA and Viramune can be co-administered without dose adjustments.
DMPA in zdravilo Viramune lahko dajemo sočasno brez prilaganja odmerkov.
DMPA AUC ↔
AUC DMPA ↔
DMPA AUC 
AUC DMPA 
DMPA Cmax 
Cmax DMPA 
DMPA Cmin 
Cmin DMPA 
DMPA/Emtricitabine
Vsadek: etonogestrel/efavirenz
DNA negative and seronegative at study entry).
DNA- negativnih in seronegativnih ob vstopu v študijo).
DNA polymerase  inhibition resulting in termination of DNA chain elongation and/or DNA synthesis / repair.
Inhibicija DNA polimeraze , zaradi katere pride do terminacije elongacije verige DNA in/ali sinteze/popravljanja DNA.
Do a final check to ensure the correct amount of liquid for your dose is in the syringe and all air bubbles have been removed.
Opravite končno preverjanje, da se boste prepričali, da je v brizgi pravilna količina tekočine za vaš odmerek in da so vsi zračni mehurčki odstranjeni.
Do check the inspection window to confirm it has turned yellow.
 Poglejte okence in se prepričajte, da je postalo rumeno.
Do check your dose before starting this step.
Pred začetkom tega koraka preverite svoj odmerek.
Do contact your healthcare provider.
Obrnite se na zdravstvenega delavca.
Do dispose of any left-over Nplate in proper waste container.
Zavrzite morebitni preostanek zdravila Nplate v ustrezen vsebnik za odpadke.
Do dispose of the used needle and syringe in a puncture-resistant container.
Zavrzite uporabljeno iglo in brizgo v vsebnik, odporen proti prebadanju.
Do dissolve slowly and carefully.
Zdravilo raztopite počasi in pazljivo.
Do ensure that all water is injected from the syringe into the vial before dissolving.
Pred raztapljanjem se prepričajte, da ste iz brizge v vialo injicirali vso vodo.
Do gently swirl the vial
Previdno vrtite vialo.
Do hold the pre-filled pen at a right angle (90º) to the injection site.
Držite napolnjeni injekcijski peresnik pravokotno (90 °) na mesto injiciranja.
Do hold the pre-filled pen at a right angle (90º) to the injection site.
 Držite napolnjeni injekcijski peresnik pravokotno (90 °) na mesto injiciranja.
Do it gently - do not shake the syringe and vial.
Brizgo in vialo premikajte nežno - ne stresajte ju.
Do it gently - do not shake the syringe and vial.
To izvajajte nežno - ne stresajte brizge in viale.
Do keep enough downward pressure to fully retract the yellow safety guard and to keep the red button unlocked.
Pritisnite navzdol dovolj močno, da se bo rumena varnostna zaščita pomaknila povsem nazaj in bo rdeči gumb ostal sproščen.
Do keep enough downward pressure to fully retract the yellow safety guard and to keep the red button unlocked.
 Pritisnite navzdol dovolj močno, da se bo rumena varnostna zaščita pomaknila povsem nazaj in bo rdeči gumb ostal sproščen.
Do maintain pressure on the skin during the injection
 Med injiciranjem pritiskajte na kožo
Do make sure all air bubbles are removed from the syringe.
Prepričajte se, da so vsi zračni mehurčki odstranjeni iz brizge.
Do make sure liquid is fully dissolved before removing syringe.
Preden odstranite brizgo, se prepričajte, da je zdravilo v tekočini povsem raztopljeno.
Do make sure that all air bubbles are removed before injection.
Pred injiciranjem preverite, da so vsi zračni mehurčki odstranjeni.
Do make sure the correct amount of liquid for your dose remains in the syringe.
Prepričajte se, da je v brizgi ostala pravilna količina tekočine za vaš odmerek.
Do no re-use the applicator tip.
Aplikacijski nastavek ni za ponovno uporabo.
Do no use in dogs less than 10 weeks of age.
Ne uporabite pri psih mlajših od 10 tednov.
Do no use in dogs less than 6 weeks of age.
Ne uporabite pri psih, mlajših od 6 tednov.
Do no vaccinate animals undergoing antibacterial treatment effective against Escherichia coli.
Ne cepite živali, ki se zdravijo z antibiotiki, učinkovitimi proti Escherichia coli.
Do not
Ne zavrzite je.
Do not  dose below Dose Level -5
Odmerka ne  zmanjšajte pod raven odmerka -5.
Do not a double dose to make up for a forgotten dose.
Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmerek.
Do not activate the purple 20 microgram Lyxumia pen until you have finished the green pen.
Ne aktivirajte škrlatnega peresnika Lyxumia 20 mikrogramov, dokler ne dokončate zelenega peresnika.
Do not add liquid to the powder in its original container
Praška ne smete mešati s tekočino v originalnem vsebniku.
Do not add or stir RAVICTI into larger volumes of liquid such as water or juice.
Ne dodajajte in ne mešajte zdravila RAVICTI v večje količine tekočin, kot so voda ali sok.
Do not administer
Ne uporabite
Do not administer BRINAVESS if you notice particulate matter or discolouration.
Zdravila BRINAVESS ne uporabite, če v njem opazite delce ali če je obarvano.
Do not administer by any other route.
Zdravila ne aplicirajte na noben drug način.
Do not administer concurrently with glucocorticoids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Ne uporabljajte hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Do not administer concurrently with glucocorticoids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Zdravila ne uporabljajte hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali z antikoagulanti.
Do not administer concurrently with glucocorticoids, other NSAIDs or with anti-coagulant agents.
Ne uporabljajte hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Do not administer concurrently with glucocorticoids, other NSAIDs or with anti-coagulant agents.
Zdravila ne uporabljajte hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali z antikoagulanti.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Ne uporabite sočasno z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulantnimi sredstvi.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Zdravila ne smemo dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Zdravila ne smete dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anticoagulant agents.
Ne dajajte sočasno s kortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali z antikoagulanti.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anticoagulant agents.
Ne uporabite sočasno z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulantnimi sredstvi.
Do not administer concurrently with glucocorticosteroids, other Non-Steroidal Anti-Inflammatory Drugs or with anticoagulant agents.
Zdravila ne smemo dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Do not administer concurrently with glucocorticosteroids, other Non-Steroidal Anti-Inflammatory Drugs or with anticoagulant agents.
Zdravila ne smete dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anticoagulant agents.
Zdravila ne smete dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulantnimi zdravili.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anticoagulant medicinal products.
Zdravila ne smemo dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulantnimi zdravili.
Do not administer concurrently with glucocorticosteroids, other NSAIDs or with anti-coagulant agents.
Zdravila ne smemo dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Do not administer if particulate matter or discoloration is found.
Raztopine z delci ali spremenjeno barvo ne smete uporabiti.
Do not administer if particulate matter or discoloration is observed.
Raztopine z delci ali spremenjeno barvo ne smete uporabiti.
Do not administer if particulate matter remains following shaking or if discoloration is observed or if the syringe appears to be physically damaged.
Če so prisotni delci ali če se zdi cepivo obarvano ali če se zdi injekcijska brizga fizično poškodovana, cepivo zavrzite.
Do not administer if particulate matter remains following shaking or if discoloration is observed or if the syringe appears to be physically damaged..
Če so prisotni delci ali če se zdi cepivo obarvano ali če se zdi injekcijska brizga fizično poškodovana, cepivo zavrzite.
Do not administer in conjunction with other medicinal products.
Ne uporabljajte skupaj z drugimi zdravili.
Do not administer in conjunction with other medicinal products.
Ne uporabljajte sočasno z drugimi zdravili.
Do not administer insulin.
Ne dajte si insulina.
Do not administer intravascularly.
Cepiva ne smete aplicirati intravaskularno.
DO NOT ADMINISTER INTRAVENOUSLY OR
NE DAJAJTE INTRAVENSKO ALI
DO NOT ADMINISTER INTRAVENOUSLY OR SUBCUTANEOUSLY
NE DAJAJTE INTRAVENSKO ALI SUBKUTANO.
DO NOT ADMINISTER INTRAVENOUSLY OR SUBCUTANEOUSLY.
NE DAJAJTE INTRAVENSKO ALI SUBKUTANO.
Do not administer intravenously or subcutaneously.
Ne injicirajte intravensko ali subkutano.
Do not administer intravenously.
Ni za intravensko dajanje.
Do not administer Kadcyla at doses greater than 3.6 mg/kg once every 3 weeks
Zdravila Kadcyla ne dajajte v odmerkih večjih od 3,6 mg/kg vsake 3 tedne.
Do not administer Kadcyla in combination with chemotherapy
Zdravila Kadcyla ne uporabljajte sočasno s kemoterapijo.
Do not administer Meloxivet:
Zdravila Meloxivet ne smete dajati:
Do not administer more than one dose per pen.
Z enim injekcijskim peresnikom ne aplicirajte več kot enega odmerka.
Do not administer OBIZUR in the same tubing or container with other medicinal products for injection.
Zdravila OBIZUR ne smete dajati v cevje ali vsebnik, ki vsebuje drugo zdravilo za injiciranje.
Do not administer orally or parenterally.
Zdravila ne dajajte peroralno in parenteralno.
Do not administer RIXUBIS by continuous infusion.
Zdravila RIXUBIS ne dajajte s kontinuirano infuzijo.
Do not administer simultaneously with other macrolides or lincosamides (see section 4.8)
Ne dajajte istočasno z drugimi makrolidi ali linkozamidi (glejte poglavje 4.8).
Do not administer Soliris as an intravenous push or bolus injection.
Zdravila Soliris ni dovoljeno dajati v obliki hitre intravenske ali bolusne injekcije.
Do not administer the product to pigs and rabbits receiving ionophores.
Ne uporabite zdravila za uporabo v veterinarski medicini pri prašičih ali kuncih, ki dobivajo ionofore.
Do not administer the product to pigs or rabbits receiving ionophores.
Ne uporabite zdravila za uporabo v veterinarski medicini pri prašičih ali kuncih, ki dobivajo ionofore.
Do not administer the veterinary medicinal product to pigs receiving monensin, salinomycin or narasin.
Ne uporabljajte zdravila za uporabo v veterinarski medicini pri prašičih, ki prejemajo monenzin, salinomicin ali narazin.
Do not administer the veterinary medicinal product to pigs receiving the ionophores monensin, salinomycin or narasin.
Ne uporabljajte zdravila za uporabo v veterinarski medicini pri prašičih, ki prejemajo ionofore monenzin, salinomicin ali narazin.
Do not administer to cats
Ne dajajte mačkam.
Do not administer to cats.
Ne dajati mačkam.
Do not administer to kittens under 8 weeks of age.
Ne dajajte mačkam, mlajšim od 8 tednov.
Do not administer to puppies under 8 weeks of age.
Ne dajajte psom, mlajšim od 8 tednov.
Do not administer to sick or debilitated dogs or dogs suffering from heat stress.
Ne dajati bolnim ali slabotnim psom ali psom prizadetim zaradi vročinskega stresa.
Do not administer trastuzumab emtansine until AST/ALT recovers to Grade ≤ 2 (>2.5 to <5 x ULN), and then dose reduce (see table 1).
Trastuzumaba emtanzina ne uporabite, dokler se AST/ALT ne vrneta na ≤ 2. stopnjo (> 2,5 do < 5 x ZNM), šele nato zmanjšajte odmerek (glejte preglednico 1).
Do not administer trastuzumab emtansine until total bilirubin recovers to Grade ≤ 1 (>ULN to 1.5x ULN), and then dose reduce (see table 1).
Trastuzumaba emtanzina ne uporabite, dokler se celokupni bilirubin ne vrne na ≤ 1. stopnjo (> ZNM do 1,5 x ZNM), šele nato zmanjšajte odmerek (glejte preglednico 1).
Do not administer trastuzumab emtansine until total bilirubin recovers to Grade  1 (>ULN to 1.5x ULN).
Trastuzumaba emtanzina ne uporabite, dokler se celokupni bilirubin ne vrne na  1. stopnjo (> ZNM do 1,5 x ZNM).
Do not administer with food since clinical trials demonstrated better efficacy of robenacoxib when administered without food or at least 30 minutes before or after a meal.
Ne dajajte s hrano, ker so klinični poskusi dokazali večjo učinkovitost robenakoksiba, če ga damo brez hrane oziroma najmanj 30 minut pred ali po obroku.
Do not administer, continue to assess the platelet count weekly
Ne uporabite zdravila, nadaljujte kontrole števila trombocitov vsak teden.
DO NOT ADMINISTER– data is unavailable for dose recommendation
NE UPORABLJAJTE – podatki za priporočila za odmerjanje niso na voljo
Do not allow animals to groom each other following treatment.
Preprečite medsebojno lizanje zdravljenih živali.
Do not allow canine, horses, other equines or guinea fowl access to formulations containing monensin.
Psi, konji, drugi kopitarji ali pegatke ne smejo imeti dostopa do zdravil, ki vsebujejo monenzin.
Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin.
Psi, konji, drugi kopitarji ali pegatke ne smejo imeti dostopa do zdravil, ki vsebujejo monenzin.
Do not allow recently treated animals to groom each other.
Ne dovolite ravnokar zdravljenim mačkam, da negujejo ena drugo.
Do not allow the medicine to freeze, and protect the medicine from light.
zmrzniti in zaš ititi ga morate pred svetlobo.
Do not allow the pen to freeze.
Ne pustite, da bi peresnik zamrznil.
Do not allow treated animals to come into contact with untreated animals until the application site is dry.
Zdravljene živali ne smejo priti v stik z nezdravljenimi, dokler ni mesto nanosa suho.
Do not apply a double amount to make up for a missed dose.
Ne nanesite dvojne količine gela, da bi nadomestili izpuščeni odmerek.
Do not apply an excessive amount of solution at any one spot which could cause some of the solution to run off the side of the animal.
Ne nanesite preveč raztopine na eno mesto, ker bi je lahko nekaj steklo ob strani dol.
Do not apply an excessive amount of solution at any one spot, as that could cause some of the product to run down the animal’s side.
Pazite, da ne nanesete na eno mesto prevelike količine zdravila, sicer bo zdravilo stekelo po boku živali.
Do not apply intravascularly.
Zdravila ne uporabljajte intravaskularno.
Do not apply more gel than your doctor has advised.
Ne nanašajte več gela, kot vam je naročil zdravnik.
Do not apply other topical preparations concomitantly to the same lesions.
Na poškodbe sočasno ne nanašajte drugih pripravkov za lokalno uporabo.
Do not apply pressure or walk on the ulcer during treatment.
Med zdravljenjem na razjedo ne smete pritiskati ali hoditi po njej.
Do not apply the cream internally.
Krema je namenjena samo za zunanjo uporabo.
Do not apply the gel on or near sensitive parts of your body such as eyes, nostrils, mouth, lips, vagina, tip of the penis, rectum, or anus.
Gela ne nanašajte na ali blizu občutljivih delov telesa, kot so oči, nosnice, usta, ustnice, vagina, glavica penisa, rektum ali anus.
Do not apply the gel to healthy skin around a KS lesion.
Gela ne nanašajte na zdravo kožo okoli KS lezije.
Do not apply the veterinary medicinal product to the surface of the dog’s hair coat.
Zdravila ne nanašajte na površino dlake.
Do not apply this medicine immediately after taking a shower or less than 2 hours before bedtime.
Tega zdravila ne nanašajte takoj po prhanju ali manj kot 2 uri pred spanjem.
Do not apply this medicine internally, to the area near the eyes, to the inside of the nostrils, the inside of the ear or on the lips.
Tega zdravila ne našajte na notranje dele, v bližino oči, na notranjo stran nosnic, notranjost ušes ali na ustnice.
Do not apply when the animal’s hair coat is wet.
Zdravila ne nanašamo na mokro dlako živali.
Do not attach a needle to the syringe
Ne natikajte igle na brizgo.
DO NOT attach needle until instructed in step B
NE namestite igle, dokler ne52 preberete navodil v koraku B.
Do not attach the needle at Step A. If the needle is attached at Step A, some of the medicine may be lost during mixing.
Ne namestite igle v koraku A. Če iglo namestite v koraku A, se lahko med mešanjem izgubi nekaj zdravila.
Do not attempt to administer an injection until you are sure that you understand how to give the injection.
Ne poskušajte si dati injekcije, dokler niste prepričani, da veste, kako se to naredi.
Do not attempt to administer an injection until you are sure that you understand how to prepare and give the injection.
Dokler niste povsem prepričani, da razumete, kako je treba odmerek pripraviti in injicirati, ne poskušajte injicirati zdravila Enbrel.
Do not attempt to administer an injection until you are sure that you understand how to use the pre-filled syringe.
Ne poskušajte si dati injekcije, dokler niste popolnoma prepri ani, da razumete, kako uporabljati napolnjeno injekcijsko brizgo.
Do not attempt to change the dose while injecting.
Med injiciranjem ne poskušajte spreminjati odmerka.
Do not attempt to crush or split the tablet.
Tablete ne drobite in ne lomite.
Do not attempt to dial past this point.
Ne poskušajte nastaviti preko te točke.
Do not attempt to give your child an injection until you are sure that you understand how to prepare and give the injection.
Ne poskušajte zdravila injicirati vašemu otroku, dokler popolnoma ne obvladate priprave in dajanja injekcije.
Do not attempt to inject your insulin by turning the Dose Knob.
Insulina ne poskušajte injicirati z obračanjem gumba za odmerjanje.
Do not attempt to inject yourself unless you are sure you understand the procedure and requirement of self- injection.
Zdravila pa si ne skušajte injicirati, če niste prepričani, da razumete postopek in zahteve za samoinjiciranje.
Do not attempt to inject yourself unless you are sure you understand the procedure and requirement of self-injection.
Zdravila si ne poskušajte injicirati, če niste prepričani, da razumete postopek in zahteve za samoinjiciranje.
Do not attempt to inject yourself unless you are sure you understand the procedure and requirements of self- injection.
Ne skušajte si injicirati zdravila, če niste prepričani, da razumete postopek in vse zahteve za samoinjiciranje.
Do not attempt to inject yourself unless you have been trained to do so by your doctor or nurse.
Ne poskušajte si zdravila injicirati sami, dokler vas zdravnik ali medicinska sestra ne naučita, kako to storiti.
Do not attempt to inject yourself unless you have been trained to do so by your doctor or nurse.
Zdravila si ne poskušajte injicirati sami, če vas tega ni naučil zdravnik ali medicinska sestra.
Do not attempt to lubricate your pen as this may damage the mechanism.
Peresnika ne poskušajte namazati, saj to lahko poškoduje mehanizem.
Do NOT attempt to push the tablet through the blister, because this can damage the tablet.
NE poskusite potisniti tablete skozi pretisni omot, ker jo lahko s tem poškodujete.
Do not attempt to self-administer Ovaleap without this training by your doctor or nurse.
Zdravila Ovaleap si ne poskušajte injicirati sami, če vas o tem nista ustrezno poučila vaš zdravnik ali medicinska sestra.
Do not attempt to snap or pull the tip off as this may damage the syringe.
Konice ne poskusite zlomiti ali povleči, saj lahko poškodujete injekcijsko brizgo.
Do not be concerned about small air bubbles, they do not need to be removed.
Za majhne zračne mehurčke ne skrbite, ker jih ni treba odstraniti.
Do not be concerned if you do not experience any of these problems.
Ne skrbite, če ne boste imeli nobenih od omenjenih težav.
Do not be discouraged if you do not see immediate improvement.
Ne odnehajte, če ne opazite takojšnjega izboljšanja.
Do not begin treatment with HyQvia at home until you have received complete instructions.
Z zdravilom HyQvia se ne začnite zdraviti doma, dokler ne prejmete vseh navodil.
Do not bend or damage the needle before use.
Pazite, da igle pred uporabo ne zvijete ali poškodujete.
Do not bend or damage the needle before use.
Pazite, da pred uporabo igle ne zvijete in ne poškodujete.
Do not bend the needle.
Igle ne upogibajte.
Do not bite, suck, chew, or swallow the tablet, as this will result in less pain relief than when taken as directed.
Tablete ne grizite, sesajte, žvečite in ne pogoltnite, saj je s tem učinek lajšanja bolečine slabši kot pri uporabi po navodilih.
Do not block the air vent with your fingers.
Pazite, da ne boste s prsti prekrili rež za zrak.
Do not block the air-vents with your fingers.
Pazi naj, da ne bo s prsti prekril rež za zrak.
Do not break or crush tablet.
Tablet ne lomite ali drobite.
Do not break or crush the tablet before taking it.
Pred jemanjem tableto ne lomite ali drobite.
Do not break or crush the tablet.
Tablet ne lomite in ne drobite.
Do not break or crush them
Kapsul ne smete lomiti ali drobiti.
Do not break or crush them.
Tablet ne smete lomiti ali drobiti.
Do not break or grind the tablets.
Ne lomite ali drobite tablet
Do not break, chew or crush the tablet.
Tablet ne lomite, žvečite ali drobite.
Do not break, chew, or empty the pellets from the capsule since this may increase the risk of bleeding.
Ne smete je žvečiti niti lomiti niti iz nje izprazniti zrnc, ker bi to lahko povečalo tveganje za krvavitev.
Do not break, crush or chew the tablet; this will affect how the tablet works.
Tablete ne zlomite, zdrobite ali žvečite; to bi vplivalo na način delovanja tablete.
Do not break, open or chew the capsules.
Kapsul ne drobite, odprite ali žvečite.
Do not break, open or chew the capsules.
Kapsul ne zdrobite, odprite ali žvečite.
Do not breast feed when taking Abraxane as it is not known if the active ingredient paclitaxel passes into the mother’s milk.
Med jemanjem zdravila Abraxane ne smete dojiti, saj ni znano, ali zdravilna učinkovina paklitaksel prehaja v materino mleko.
Do not breast- feed while you are taking Zavesca.
V času jemanja zdravila Zavesca ne smete dojiti.
Do not breast-feed during the treatment with Glivec.
Med zdravljenjem z zdravilom Glivec ne dojite.
Do not breast-feed during the treatment with Imatinib Accord.
Med zdravljenjem z zdravilom Imatinib Accord ne dojite.